Circulating N-Linked Glycoprotein Side-Chain Biomarker, Rosuvastatin Therapy, and Incident Cardiovascular Disease: An Analysis From the JUPITER Trial.

MLA

Akinkuolie, Akintunde O., et al. “Circulating N-Linked Glycoprotein Side-Chain Biomarker, Rosuvastatin Therapy, and Incident Cardiovascular Disease: An Analysis From the JUPITER Trial.” Journal of the American Heart Association, vol. 5, no. 7, July 2016. EBSCOhost, https://doi.org/10.1161/JAHA.116.003822.

APA

Akinkuolie, A. O., Glynn, R. J., Padmanabhan, L., Ridker, P. M., & Mora, S. (2016). Circulating N-Linked Glycoprotein Side-Chain Biomarker, Rosuvastatin Therapy, and Incident Cardiovascular Disease: An Analysis From the JUPITER Trial. Journal of the American Heart Association, 5(7). https://doi.org/10.1161/JAHA.116.003822

Chicago

Akinkuolie, Akintunde O, Robert J Glynn, Latha Padmanabhan, Paul M Ridker, and Samia Mora. 2016. “Circulating N-Linked Glycoprotein Side-Chain Biomarker, Rosuvastatin Therapy, and Incident Cardiovascular Disease: An Analysis From the JUPITER Trial.” Journal of the American Heart Association 5 (7). doi:10.1161/JAHA.116.003822.